Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCα and Src inhibitors

Genetic Alterations during Colorectal-Tumor Development

Bert Vogelstein, Eric R. Fearon, Stanley R. Hamilton et al. · New England Journal of Medicine · 1988 · 6.8K citations

Medicine, Genetics, Oncology +14

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Yoichi Nagata, Keng‐Hsueh Lan, Xiaoyan Zhou et al. · Cancer Cell · 2004 · 1.9K citations · Full text

Medicine, Cancer Biology, Oncology +14

Overexpression of ErbB2 Blocks Taxol-Induced Apoptosis by Upregulation of p21Cip1, which Inhibits p34Cdc2 Kinase

Dihua Yu, Bolin Liu, Jun Yao et al. · Molecular Cell · 1998 · 353 citations · Full text

Life Sciences, Cell Biology, Oncology +14

Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis

Susan E. Moody, Christopher J. Sarkisian, Kristina Hähn et al. · Cancer Cell · 2002 · 353 citations · Full text

Medicine, Cancer Biology, Oncology +16

Activation of the Akt/Mammalian Target of Rapamycin/4E-BP1 Pathway by ErbB2 Overexpression Predicts Tumor Progression in Breast Cancers

Xiaoyan Zhou, Ming Tan, Valerie Stone Hawthorne et al. · Clinical Cancer Research · 2004 · 312 citations · Full text

Medicine, Cancer Biology, Oncology +17